Digital Immunoassay for Rapid Detection of SARS-CoV-2 Infection in a Broad Spectrum of Animals

Siyan Li,Weijing Wang,Weinan Liu,Chi Chen,Skye Shephard,Fangfeng Yuan,Jennifer M Reinhart,Diego Diel,Brian Cunningham,Ying Fang
DOI: https://doi.org/10.1101/2024.06.21.600129
2024-06-24
Abstract:The ability of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) to infect a wide-range of species raises significant concerns regarding both human-to-animal and animal-to-human transmission. There is an increasing demand for highly sensitive, rapid, and simple diagnostic assays that can detect viral infection across various species. In this study, we developed a biosensor assay that adapted a monoclonal-antibody (mAb)-based blocking ELISA format into an Activate Capture + Digital Counting (AC + DC)-based immunoassay. The assay employs a photonic crystal (PC) biosensor, gold-nanoparticle (AuNP) tags, SARS-CoV-2 nucleocapsid (N) protein, and specific anti-N mAb to detect antibody responses in animals exposed with SARS-CoV-2. We demonstrated a simple 2-step 15-min test that was capable of detecting as low as 12.5 ng of antibody in controlled standard serum samples. Based on an evaluation of 176 cat serum samples with known antibody status, an optimal percentage of inhibition (PI) cut-off value of 0.588 resulted in a diagnostic sensitivity of 98.3% and a diagnostic specificity of 96.5%. The test is highly repeatable with low variation coefficients of 2.04%, 2.73%, and 4.87% across different runs, within a single run, and on a single chip, respectively. The test was further employed to detect antibody responses in multiple animal species as well as investigate dynamics of antibody response in experimentally infected cats. This test platform provides an important tool for rapid field surveillance of SARS-CoV-2 infection across multiple species.
Microbiology
What problem does this paper attempt to address?
The main objective of this paper is to develop a digital immunoassay method for the rapid detection of SARS-CoV-2 infection in multiple animal species. Specifically, the research team designed a novel biosensor assay method that combines a monoclonal antibody (mAb) blocking ELISA format with an activation capture + digital counting (AC + DC) immunoassay. This method utilizes photonic crystal (PC) biosensors, gold nanoparticles (AuNP) labels, SARS-CoV-2 nucleocapsid (N) protein, and monoclonal antibodies specific to the N protein to detect the antibody response in animals exposed to the SARS-CoV-2 virus. This method can complete the detection within 15 minutes and has high sensitivity and specificity. By evaluating cat serum samples with known antibody status, the optimal inhibition percentage (PI) cutoff value was determined to be 0.588, which resulted in a diagnostic sensitivity of 98.3% and a specificity of 96.5%. Additionally, the test method demonstrated high reproducibility, with coefficients of variation of 2.04%, 2.73%, and 4.87% corresponding to intra-chip, intra-run, and inter-run variations, respectively. This method is not only applicable to cats but has also been used to detect antibody responses in various other animal species and to explore the dynamics of antibody changes in experimentally infected cats. In summary, this study developed a rapid, simple, and highly sensitive on-site monitoring tool for the rapid screening of SARS-CoV-2 infection in multiple species, aiding in the understanding and control of cross-species transmission issues.